GEFFY 250MG TABLETS Substitute
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
GEFITINIB-250MG
Uses:
Treatment of Non-small cell lung cancer
Medicinal Benefits:
GEFFY 250MG TABLETS is indicated to the patients dealing with non-small cell lung cancer. Cancer of this type tends to spread quickly in other parts of the body. GEFFY 250MG TABLETS travels through the bloodstream and effectively destroys cancerous cells of the lung and other parts of the body. GEFFY 250MG TABLETS is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. It acts by stopping the abnormal protein action that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed, it undergoes a usual process of maturity. Cancerous cells form new cells more quickly, so GEFFY 250MG TABLETS targets cancerous cells and blocks the action of Tyrosine kinase enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, GEFFY 250MG TABLETS stops the production, spread and growth of cancerous cells in the body.
GEFFY 250MG TABLETS is used to treat non-small cell lung cancer.
GEFFY 250MG TABLETS works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. Thereby, it prevents the spread of cancerous cells.
The most common sign of lung cancer is a cough that lasts long and gets worse with time. Sometimes, a patient may notice blood in the cough. Chest pain is also a sign of lung cancer followed by coughing.
It is suggested to avoid taking an antacid or stomach acid-reducing medicine within 6 hours after taking GEFFY 250MG TABLETS as it may make the medicine less effective if taken simultaneously.
GEFFY 250MG TABLETS is safe to be taken by a diabetic person. However, take GEFFY 250MG TABLETS only after asking a doctor as they may adjust the dosing according to the patient's condition.